| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Ovid Therapeutics Inc. | Chief Operating Officer | Common Stock | 28,125 | $60,469 | $2.15 | 22 Feb 2024 | Direct |
| IMMUNIC, INC. | President and COO | Common Stock | 12,512 | $9,884 | $0.7900 | 05 Jun 2025 | Direct |
| IMMUNIC, INC. | President and COO | Stock Option | 598,500 | 05 Jun 2025 | Direct | ||
| IMMUNIC, INC. | President and COO | Stock Appreciation Right | 330,000 | 16 Jul 2025 | Direct | ||
| Ovid Therapeutics Inc. | Chief Operating Officer | Stock Option (Right to Buy) | 168,750 | 22 Feb 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| IMUX | IMMUNIC, INC. | 16 Jul 2025 | 5 | $0 | 4 | President and COO | 18 Jul 2025, 16:05 |
| IMUX | IMMUNIC, INC. | 05 Jun 2025 | 2 | +$9,884 | 4/A | President and COO | 20 Jun 2025, 17:16 |
| IMUX | IMMUNIC, INC. | 04 Dec 2024 | 1 | $0 | 4 | President and COO | 06 Dec 2024, 17:31 |
| IMUX | IMMUNIC, INC. | 12 Jul 2024 | 1 | $0 | 4 | President and COO | 12 Jul 2024, 08:31 |
| IMUX | IMMUNIC, INC. | 12 Jul 2024 | 0 | $0 | 3 | President and COO | 12 Jul 2024, 08:31 |
| OVID | Ovid Therapeutics Inc. | 22 Feb 2024 | 2 | $0 | 4 | Chief Operating Officer | 26 Feb 2024, 18:05 |
| OVID | Ovid Therapeutics Inc. | 23 Feb 2023 | 1 | $0 | 4 | Chief Operating Officer | 27 Feb 2023, 16:27 |
| OVID | Ovid Therapeutics Inc. | 12 Sep 2022 | 1 | -$37,290 | 4 | Chief Operating Officer | 14 Sep 2022, 16:58 |
| OVID | Ovid Therapeutics Inc. | 08 Apr 2022 | 2 | $0 | 4 | Chief Operating Officer | 12 Apr 2022, 17:40 |
| OVID | Ovid Therapeutics Inc. | 03 Feb 2022 | 1 | $0 | 4 | Chief Operating Officer | 04 Feb 2022, 17:24 |
| OVID | Ovid Therapeutics Inc. | 01 Jul 2021 | 1 | $0 | 4 | Chief Commercial Officer | 01 Jul 2021, 16:23 |